These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31306728)
1. Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas. Shi K; Zhang B; Kong BY; Zhang Y; Igartua C; Mohan LS; Quan VL; Panah E; Isales MC; Beaubier N; Taxter TJ; White KP; Zou L; Gerami P J Am Acad Dermatol; 2023 May; 88(5):1051-1059. PubMed ID: 31306728 [TBL] [Abstract][Full Text] [Related]
2. GAB2 amplifications refine molecular classification of melanoma. Chernoff KA; Bordone L; Horst B; Simon K; Twadell W; Lee K; Cohen JA; Wang S; Silvers DN; Brunner G; Celebi JT Clin Cancer Res; 2009 Jul; 15(13):4288-91. PubMed ID: 19509136 [TBL] [Abstract][Full Text] [Related]
3. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas. Rawson RV; Johansson PA; Hayward NK; Waddell N; Patch AM; Lo S; Pearson JV; Thompson JF; Mann GJ; Scolyer RA; Wilmott JS Lab Invest; 2017 Feb; 97(2):130-145. PubMed ID: 28067894 [TBL] [Abstract][Full Text] [Related]
4. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes. Wang M; Banik I; Shain AH; Yeh I; Bastian BC Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047 [TBL] [Abstract][Full Text] [Related]
5. Distinct sets of genetic alterations in melanoma. Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983 [TBL] [Abstract][Full Text] [Related]
6. KIT amplification and gene mutations in acral/mucosal melanoma in Korea. Yun J; Lee J; Jang J; Lee EJ; Jang KT; Kim JH; Kim KM APMIS; 2011 Jun; 119(6):330-5. PubMed ID: 21569090 [TBL] [Abstract][Full Text] [Related]
7. Targeted Genomic Profiling of Acral Melanoma. Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954 [TBL] [Abstract][Full Text] [Related]
9. Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure. Haugh AM; Zhang B; Quan VL; Garfield EM; Bubley JA; Kudalkar E; Verzi AE; Walton K; VandenBoom T; Merkel EA; Lee CY; Tan T; Isales MC; Kong BY; Wenzel AT; Bunick CG; Choi J; Sosman J; Gerami P J Invest Dermatol; 2018 Feb; 138(2):384-393. PubMed ID: 28870692 [TBL] [Abstract][Full Text] [Related]
10. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure. Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873 [TBL] [Abstract][Full Text] [Related]
11. Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling. Zou Z; Ou Q; Ren Y; Lv Q; Qin L; Zhao L; Su S; Wu X; Bao H; Wang A; Zhu D; Wang X; Shao YW; Liu B Pigment Cell Melanoma Res; 2020 Jul; 33(4):601-611. PubMed ID: 31944535 [TBL] [Abstract][Full Text] [Related]
12. Targeted Therapy and Immunotherapy for Melanoma in Japan. Namikawa K; Yamazaki N Curr Treat Options Oncol; 2019 Jan; 20(1):7. PubMed ID: 30675668 [TBL] [Abstract][Full Text] [Related]
13. Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data. Hida T; Kato J; Idogawa M; Tokino T; Uhara H Int J Clin Oncol; 2024 Sep; ():. PubMed ID: 39249554 [TBL] [Abstract][Full Text] [Related]
14. Somatic activation of KIT in distinct subtypes of melanoma. Curtin JA; Busam K; Pinkel D; Bastian BC J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas. Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970 [TBL] [Abstract][Full Text] [Related]
20. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]